The government is going to counter ‘misinformation’

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28
250
The government is going to counter ‘misinformation’ about GMO foods

WTF?????

https://www.washingtonpost.com/news/wonk/wp/2...7daafbe3fa

The Food and Drug Administration will fund a campaign to promote genetically modified organisms in food under a bipartisan agreement to keep the government funded through the end of September.

The deal to avert a government shutdown allocates $3 million to “consumer outreach and education regarding agricultural biotechnology,” which includes genetic engineering of food and commodity crops. The money is to be used to tout “the environmental, nutritional, food safety, economic, and humanitarian impacts” of biotech crops and their derivative food products.

[We're having the wrong argument about GMOs]

More than 50 agriculture and food industry groups had signed on to an April 18 letter urging the funding to counter “a tremendous amount of misinformation about agricultural biotechnology in the public domain.” But some environmental groups and House Democrats have derided the provision as a government-sponsored public relations tour for the GMO industry.

“It is not the responsibility of the FDA to mount a government-controlled propaganda campaign to convince the American public that genetically modified foods are safe,” said Rep. Nita M. Lowey (D-N.Y.), who attempted to get the measure struck from the bill last month. “The FDA has to regulate the safety of our food supply and medical devices. They are not, nor should they be, in the pro-industry advertising business,” Lowey said during a congressional hearing

It’s unclear what the FDA campaign will look like, or when it will launch. The $3 million allocated is little more than a speck in the FDA’s total allocated budget of $2.8 billion.

The budget specifies only that the initiative be developed in collaboration with the Department of Agriculture, and include the “publication and distribution of science-based educational information.” An attempt by Democrats to redirect the project’s funding to pediatric medical projects within FDA was unanimously voted down by Republicans.

A 2016 study by the Pew Research Center found that 39 percent of American adults believe that genetically modified foods are worse for health than their conventional equivalents — an assessment with which the vast majority of scientists disagree. Nearly 90 percent of the members of the American Association for the Advancement of Science believe GMOs are safe to eat, according to another Pew study.

“Clearly, communication of the benefits of biotechnology from the scientific community has not gone well, and this presents an opportunity to engage with the public in a more meaningful dialogue,” said Mark Rieger, the dean of the University of Delaware’s College of Agriculture and Natural Resources, who signed the industry letter. “We see it as a communication issue, not a political one.”

But critics argue the issue is inherently political, given the financial ties between lawmakers and the ag biotech industry. According to the Center for Responsive Politics, agribusiness interests donated more than $26.3 million to political campaigns, including those of several congressmen who sit on the House agriculture appropriations subcommittee.

Rep. Robert B. Aderholt (R-Ala.), the chair of that subcommittee and a defender of the GMO education funding, received $10,000 from Monsanto in 2016.

“This is a really clear example of big ag influencing policy,” said Dana Perls, the senior food and technology campaigner for the environmental group Friends of the Earth. “The Trump administration is putting big ag before consumer desire and public health … Consumers do not want this.”

Critics have also questioned whether it’s the government’s job to communicate this particular information — and whether that information, as written in the budget, oversteps what scientists really know. While there’s a widespread consensus that GM crops are safe, there are valid and lingering questions about the environmental and social impacts of GMOs.

Last year, an academic analysis of 14 years of farm data found that an uptick in GM seed plantings goes hand-in-hand with increased herbicide use, for instance. Some herbicides have been found to contribute to health problems in animals and humans.

Many of the touted benefits of GMOs haven’t materialized, either, argues Andy Kimbrell, the executive director of the Center for Food Safety, a D.C. nonprofit that has filed numerous legal challenges against the makers of GM crops.

An October analysis by the New York Times found that the technology does not significantly increase yields. And few GM products with tangible consumer benefits — such as better taste or nutrition — have yet made it onto the U.S. market.

“So yes, that gives them a marketing problem,” Kimbrell said. “But Monsanto has plenty of money to advocate for GMOs ... Why do we need to use taxpayer dollars?”

One possible answer, from industry’s perspective, is that taxpayer dollars are already funding a Department of Agriculture initiative to label GM foods. Last year, Congress passed a bill mandating that food companies disclose the GM ingredients in their products, and USDA has said it is actively working on the standards for those labels.

Patrick Delaney, a spokesman for the American Soybean Association, said it will be important for consumers to understand those labels once they roll out, likely after September 2018.

“We recognize that there is a need for better and more accessible information on what this technology is and what it provides to consumers, he said by email. “We supported (and still support) that $3 million in funding for biotech education ... to better inform the public about the use of biotechnology in food and agricultural production.”
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investcorp's Strong 2026: A Deep Dive into Key Moves

Updated Category News Views 101

Diving into Investcorp's Robust 2026 Performance If you're clued into the investment scene, you'll know that a $65.2 billion asset base isn't small potatoes. At the Gateway Gulf 2026, Investcorp didn't just present numbers—they laid out a dramatic year of action packed with billion-dollar dreams. While the dust hasn't quite settled yet, the first nine months of the year...

Continue Reading
SICO Snags $1.6B in New Investor Mandates for 2026

Updated Category News Views 110

SICO Makes Waves with Massive New Business Wins Right out of the gate at the Gateway Gulf 2026 Forum, SICO's announcement of a whopping $1.6 billion in new business mandates had even the seasoned pros raising an eyebrow or two. There's nothing like a sweet billion-dollar figure to kickstart the day, huh? This isn't small change we're talking about; this is a tidal wave of...

Continue Reading
Perion Acquisition: Affle's Bold Leap in Ad Tech

Updated Category News Views 153

Affle's Strategic Acquisition of Perion Jumpin' through another hoop, Affle is gearing up to snag Perion in a hefty deal valued at about $420 million. For those of you not knee-deep in the ad tech sandbox, Affle—trading on the NSE as AFFLE—is aiming to ramp up its AI-driven conversion game by absorbing Perion, a veteran in the omnichannel advertising realm. "This...

Continue Reading
Can AI Help Climate? Tech Investments Seek Balance

Updated Category News Views 376

Is AI a Climate Savior or a Power-Hungry Beast? AI might feel like that unpredictable family member you hope shows up to the party with something useful, but they’ve always got high energy bills. As the tech world touts artificial intelligence as the next big hope for addressing climate woes, folks like Peter Gilmer—who's been around a few boardrooms—are taking a...

Continue Reading
Ensuring Flooring Stability: Acclimation's Key Role

Updated Category News Views 201

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

Continue Reading
Decoding LRV: Smart Paint Choices for Your Home

Updated Category News Views 194

Unraveling the Secrets of LRV Nobody thought analyzing paint meant diving into light reflectance values (LRV), but that's precisely where we're headed today. Painting a room seems simple until you realize your color choice might turn your bright haven into a cave or vice versa. Thanks to some insights from Wendy Anguiano in HelloNation, let's dig into this technical...

Continue Reading
Extend Your Water Heater's Life with Anode Care

Updated Category News Views 297

Small Component, Big Impact: The Anode Rod Picture this: You’ve got a trusty water heater keeping your showers steamy, but lurking inside is a villain called rust. Enter the unsung hero—the anode rod. It might not be glamorous, but this little piece of metal works overtime to save your tank from a watery grave. Tim Fessler and Dave Super, seasoned plumbing hotshots...

Continue Reading
Orthocell's Remplir™ Hits Record U.S. Sales in October

Updated Category News Views 126

Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...

Continue Reading
Smart Salary Moves for S Corp Owners: Riggs Unpacks Insights

Updated Category News Views 222

Decoding the S Corp Salary Dance How much salary should the savvy owners of S corporations draw? It ain't a simple task or one-size-fits-all deal, folks. David Riggs spills the beans on HelloNation, sharing insights on this complex tango between drawing wages and raking in shareholder distributions. In the end, it’s about playing by the IRS rules—or risking a penalty...

Continue Reading
CPC's Rigorous Self-Governance Balances Power Effectively

Updated Category News Views 241

What's the Deal With Those Ancient Quotes? There's nothing like a quote from the Warring States Period to set the stage for good ol' fashioned governance chatter. Lu Buwei's words about rulers and compass points is historic, sure, but it speaks to the core need for standards in today's China. This isn't just some fortune cookie wisdom; it's a clarion call for order and...

Continue Reading

Top 5 Most Recently Viewed Articles

MDWerks Unveils Exciting Developments and Growth Plans

Updated Category News Views 275

MDWerks Provides Insightful Shareholder Update MDWerks, Inc. (OTCQB: MDWK), a pioneering company leading the way in sustainable technology, has shared a significant update from its Chief Executive Officer, Steven Laker, that outlines recent developments and future strategies. Reflecting on Progress As we analyze the performance from the first quarter of 2025, the company...

Continue Reading
Exploring the Intersection of Art and Technology at Biennale

Updated Category News Views 268

Future Innovations in Art and Technology The China (Hangzhou) Art and Technology Biennale recently launched at the Yuhang Art Museum, serving as a significant platform for cultural exchange and artistic expression. This remarkable event, organized by the China Academy of Art (CAA) along with various art institutions and governmental bodies, showcases a diverse range of...

Continue Reading
Important Opportunities for Elanco Investors Amid Legal Action

Updated Category News Views 90

Understanding the Elanco Animal Health Investor Landscape Investors in Elanco Animal Health Incorporated, notably trading under the ticker ELAN, are facing a critical juncture. With the current securities class action lawsuit in motion, it is vital for stakeholders to be aware of their rights and the importance of timely legal representation. Class Action Compliance: Key...

Continue Reading
Aurion Biotech Introduces Vyznova for Corneal Treatment

Updated Category News Views 262

Aurion Biotech Launches Vyznova for Corneal Treatment Aurion Biotech, a notable clinical-stage biotechnology company, is excited to announce the commercial launch of Vyznova (generic name: neltependocel) in Japan. This groundbreaking therapy brings renewed hope to patients suffering from bullous keratopathy of the cornea, representing a significant milestone in the field...

Continue Reading
Exploring the Future of the Global Less-Than-Truckload Market

Updated Category News Views 129

The Growth of the Less-Than-Truckload (LTL) Market The global less-than-truckload (LTL) market is predicted to witness remarkable growth in the coming years, with projections suggesting an increase of **USD 110.7 billion from 2025 to 2029**. This growth trajectory is expected to unfold at a compound annual growth rate (CAGR) of **6.8%** during the forecast period. Such...

Continue Reading